Related Experiment Video
Updated: Feb 26, 2026

Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis
Published on: January 7, 2019
Peptide Receptor Radionuclide Therapy-Induced Gitelman-like Syndrome
Aurelio Negro1, Giovanni M Rossi2, Davide Nicoli3
1Internal Medicine and Hypertension Unit, IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
Peptide receptor radionuclide therapy (PRRT) can cause kidney toxicity, presenting as a Gitelman-like syndrome with electrolyte imbalances. Close monitoring of electrolytes is crucial for patients undergoing PRRT to prevent serious complications.
Area of Science:
- Oncology
- Nephrology
- Radiology
Background:
- Peptide receptor radionuclide therapy (PRRT) targets somatostatin receptor-expressing neuroendocrine tumors.
- Known PRRT toxicities include myelotoxicity and nephrotoxicity, often with delayed onset.
- Nephrotoxicity typically presents as reduced kidney function.
More Related Videos
09:06Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
Published on: February 3, 2023
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
Related Concept Videos
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists